A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice.
There is a marked difference in insulin secretion between the ob+/ob+ obese mouse and its non-obese littermate. Numerous peptides have been implicated in the modification of postprandial insulin secretion. In this study, the morphological and immunohistochemical studies of the genetically obese mouse (ob+/ob+) pancreata were compared with control littermates. Additionally, the distribution of gastric inhibitory polypeptide, somatostatin, glucagon, and insulin immunoreactive cells was also quantitated. Hyperglycemia and hyperinsulinemia were verified in the obese mice. The control animals had some islets and ductules with mononuclear infiltrations of a possible immune character. The obese individuals had a marked increase in both number and size of the islets of Langerhans compared with lean controls. The insulin immunocytochemical reaction in the obese pancreatic beta-cells was weaker than that of controls, as was the aldehyde-fuchsin reaction. The glucagon, gastric inhibitory polypeptide, and somatostatin containing cells were intermingled with the beta-cells. In contrast, the control animals showed a peripheral localization of these cell types. The morphometric analysis of the obese pancreas showed a decreased proportion of non-beta cells within the islets but not in total pancreatic volume in comparison with controls. The obese mouse also had cavities filled with eosin-stained material among numerous beta-cells. No complete epithelial lining distinguished these formations from the surrounding islet cells. The content of the cavities was not stained by any of the immunocytochemical reactions applied. In conclusion, the pancreatic islets of the ob+/ob+ mouse show marked differences in both morphological and immunocytochemical characteristics if compared with control littermates. These differences in architecture may be related to the eventual development of diabetes mellitus in the ob+/ob+ mouse.
University of Nevada, School of Medicine, Reno.
G H
GH
Starich
M
M
Zafirova
R
R
Jablenska
P
P
Petkov
C K
CK
Lardinois
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D005749:Gastric Inhibitory Polypeptide / Q000032:analysis*; D005934:Glucagon / Q000032:analysis*; D007124:Immunoenzyme Techniques; D007328:Insulin / Q000032:analysis* / Q000097:blood; D007515:Islets of Langerhans / Q000166:cytology* / Q000473:pathology; D051379:Mice; D008820:Mice, Obese; D009765:Obesity / Q000473:pathology; D012016:Reference Values; D013004:Somatostatin / Q000032:analysis*
D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; D005749:Gastric Inhibitory Polypeptide; D005934:Glucagon